| About the author: |
R. A. Rzayeva, N. B. Karimova, M. R. Abbasova, Y. Z. Gurbanov |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
In this article, the results of the frequency of registered cases of multifocal atherosclerosis and plural atherosclerotic plaques in the different vessels of patients with diabetes mellitus type 2 and its combination with metabolic syndrome are presented. It is shown, that in patients with type 2 diabetes mellitus with and without metabolic syndrome, more often both multifocal atherosclerosis and plural atherosclerotic plaques are determined. The incidence of multifocal atherosclerosis was significantly higher in patients with diabetes mellitus (regardless of the presence of concomitant metabolic syndrome) compared to patients without diabetes and metabolic syndrome of similar age and sex composition. Only in patients with diabetes mellitus type 2 and its combination with metabolic syndrome plural atherosclerotic plaques in the same vessels in contrast to patients without diabetes and metabolic syndrome were discovered. Thus, a significant effect of diabetes mellitus on the rapid development and progression of atherosclerosis, which is exacerbated with the accession of the metabolic syndrome, has been demonstrated. |
| Tags |
type 2 diabetes mellitus,metabolic syndrome,atherosclerosis,atherosclerotic plaques,large vessels |
| Bibliography |
- BMJ. Group and best practice. Metabolic syndrome diagnostic criteria [electronic resource]. Available at: https://www.bmj.com/content/suppl/2006/03/01/bmj.38766.624097.1F.DC1.
- Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Care. 2016; 39:686–693. doi: 10.2337/dc15-1990.
- Maguire EM, Pearce SWA, Xiao Q. Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease. Vasc. Pharmacol. 2019; 112:54–71. doi: 10.1016/j.vph.2018.08.002.
- Miname MH, Santos RD. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management. Prog. Cardiovasc. Dis. 2019; 62:414–422. doi: 10.1016/j.pcad.2019.10.003.
- Pacific W. Global report on diabetes. WHO. 2023. 20–31.
- Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020 Mar 6;21(5):1835. doi: 10.3390/ijms21051835.
- Summerhill VI, Grechko AV, Yet SF, Sobenin IA, Orekhov AN. The atherogenic role of circulating modified lipids in atherosclerosis. Int. J. Mol. Sci. 2019; 20:3561. doi: 10.3390/ijms20143561.
- Taleb S. Inflammation in atherosclerosis. Arch. Cardiovasc. Dis. 2016; 109:708–715. doi: 10.1016/j.acvd.2016.04.002.
- Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):1269–1324. doi: 10.1161/HYP.0000000000000066.
- Xepapadaki E, Zvintzou E, Kalogeropoulou C, Filou S, Kypreos KE. Τhe Antioxidant Function of HDL in atherosclerosis. Angiology. 2020; 71:112–121. doi: 10.1177/0003319719854609.
- Zhdan VM, Tkachenko MV, Kіtura EM, Babanina MY, Kyrian OA. Osteoarthritis and metabolic syndrome: unity of pathogenetic mechanisms. World of Medicine and Biology. 2021; 4 (78): 56–60. doi:10.26724/2079-8334-2021-4-78-56-60.
|
| Publication of the article |
«World of Medicine and Biology» №3(89), 2024 year, 149-152 pages, index UDK 616.13-004.6; 616.379-008.64 |
| DOI |
10.26724/2079-8334-2024-3-89-149-152 |
